Showing 1181-1190 of 1645 results for "".
Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
https://practicalneurology.com/programs/cme/burden-beyond-the-patient-aads-impact-on-patients-and-caregivers/27094/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Status Migrainosus
https://practicalneurology.com/diseases-diagnoses/headache-pain/status-migrainosus/31902/Outpatient management of status migrainosus is possible and often preferable.Movement Disorders Moment: Treatment Approaches to Cervical Dystonia
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-treatment-approaches-to-cervical-dystonia/31720/Botulinum toxins are effective treatment.Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know
https://practicalneurology.com/programs/cme/early-warning-clinical-signs-of-aad-every-pcp-and-caregiver-should-know/27095/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Discontinuing Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapies-in-multiple-sclerosis/31875/Over the course of multiple sclerosis, there may come a point where the risks of disease-modifying therapies outweigh the benefits.Proactive Screening: Essential Tools for Diagnosing AAD Quickly
https://practicalneurology.com/programs/cme/proactive-screening-essential-tools-for-diagnosing-aad-quickly/27096/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Spinal Muscular Atrophy is Now a Treatable Genetic Condition
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-is-now-a-treatable-genetic-condition/32025/Multiple therapy options are available for the treatment of people with spinal muscular atrophy, a genetic disorder presenting with a wide range of symptoms and severity.Catamenial Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/catamenial-epilepsy/31944/Understanding the underlying hormone pathophysiology and types of catamenial epilepsy is necessary for determining treatment options.Rehabilitation for People with Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rehabilitation-for-people-with-movement-disorders/32043/There are 2 main objectives to neurologic rehabilitation for people with movement disorders: 1) to maintain body structure and 2) to maximize functional skills.